William R. Jellison's most recent trade in Avient Corp was a trade of 1,187 Common Stock done . Disclosure was reported to the exchange on June 30, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 1,187 | 22,622 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc. | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2025 | 14,164 | 20,403 (0%) | 0% | 0 | Common Stock | |
| Masimo Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 1,790 | 1,790 (0%) | 0% | 0 | Common Stock | |
| Masimo Corp | William R. Jellison | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 29 Apr 2025 | 1,790 | 0 | - | - | Restricted Stock Units | |
| Masimo Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Apr 2025 | 1,225 | 1,225 | - | - | Restricted Stock Units | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 1,055 | 21,435 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 955 | 20,380 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 775 | 19,425 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc. | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jul 2024 | 5,771 | 6,239 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 806 | 18,650 (0%) | 0% | 0 | Common Stock | |
| Anika Therapeutics Inc. | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2024 | 468 | 3,168 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Mar 2024 | 808 | 17,844 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | Jellison William R. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Dec 2023 | 834 | 17,036 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 984 | 16,202 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 863 | 15,218 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 857 | 14,355 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 1,040 | 13,498 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 1,139 | 12,458 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 1,139 | 12,458 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 880 | 11,319 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 717 | 10,439 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 744 | 9,095 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 669 | 8,351 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 682 | 7,682 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2020 | 1,202 | 35,526 (0%) | 0% | 0 | Common Stock | |
| Avient Corp | William R. Jellison | Director | Grant, award, or other acquisition of securities at price $ 27.04 per share. | 30 Sep 2020 | 1,109 | 36,635 (0%) | 0% | 27.0 | 29,987 | Common Stock |